| Tap a line for its trend | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22Mar 2022 | FY21 and earlierAlpha Plus |
|---|
| 194.12× | 196.96× | 182.63× | 223.03× | FY21 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 86.80× | 88.08× | 80.69× | 82.83× | ||
| 314.11× | 315.05× | 251.73× | 259.56× | ||
| −33.19× | −30.01× | 11.59× | 46.30× | ||
| 0.99× | 1.02× | 1.05× | 0.95× | ||
| — | −12.78× | 24.27× | 2.77× | ||
| — | 1.52× | 1.63× | 0.69× |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY22 31/03/2022 | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | |
|---|---|---|---|---|---|
| Inventory Days (DIO) | 223.03 | 182.63 | 196.96 | 194.12 | |
| Receivable Days (DSO) | 82.83 | 80.69 | 88.08 | 86.80 | |
| Payable Days (DPO) | 259.56 | 251.73 | 315.05 | 314.11 | |
| Cash Conversion Cycle (days) | 46.30 | 11.59 | -30.01 | -33.19 | |
| Asset Turnover | 0.95 | 1.05 | 1.02 | 0.99 | |
| Cash Conversion (CFO/Net Income) | 2.77 | 24.27 | -12.78 | — | |
| CFO/EBITDA | 0.69 | 1.63 | 1.52 | — |